Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

PHASE3RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

March 27, 2026

Study Completion Date

July 4, 2026

Conditions
C3G
Interventions
DRUG

Placebo

Placebo to iptacopan 200mg b.i.d. (Adults 200mg b.i.d; Adolescents 2x 100mg b.i.d)

DRUG

iptacopan

iptacopan 200 mg b.i.d. (Adults 200mg b.i.d; Adolescents 2x 100mg b.i.d)

Trial Locations (81)

1011

WITHDRAWN

Novartis Investigative Site, Lausanne

2650

WITHDRAWN

Novartis Investigative Site, Edegem

3000

WITHDRAWN

Novartis Investigative Site, Leuven

3010

RECRUITING

Novartis Investigative Site, Bern

10032

RECRUITING

Col Uni Med Center New York Presby, New York

12208

WITHDRAWN

Albany Medical Center, Albany

12808

COMPLETED

Novartis Investigative Site, Prague

13385

WITHDRAWN

Novartis Investigative Site, Marseille

20122

RECRUITING

Novartis Investigative Site, Milan

20246

RECRUITING

Novartis Investigative Site, Hamburg

21287

WITHDRAWN

Johns Hopkins Hospital, Baltimore

24020

RECRUITING

Novartis Investigative Site, Ranica

28041

COMPLETED

Novartis Investigative Site, Madrid

29010

WITHDRAWN

Novartis Investigative Site, Málaga

30046

RECRUITING

Georgia Nephrology Research Inst, Lawrenceville

30625

WITHDRAWN

Novartis Investigative Site, Hanover

33155

RECRUITING

Nicklaus Childrens Hospital, Miami

34093

RECRUITING

Novartis Investigative Site, Istanbul

34098

WITHDRAWN

Novartis Investigative Site, Istanbul

34295

RECRUITING

Novartis Investigative Site, Montpellier

38039

RECRUITING

Novartis Investigative Site, Talas Kayseri

41009

RECRUITING

Novartis Investigative Site, Seville

45147

COMPLETED

Novartis Investigative Site, Essen

46520

WITHDRAWN

Novartis Investigative Site, Port de Sagunt

49202

RECRUITING

Novartis Investigative Site, Petah Tikva

52074

WITHDRAWN

Novartis Investigative Site, Aachen

52242

RECRUITING

University of Iowa Health Care, Iowa City

55131

RECRUITING

Novartis Investigative Site, Mainz

59037

COMPLETED

Novartis Investigative Site, Lille

69120

RECRUITING

Novartis Investigative Site, Heidelberg

71110

RECRUITING

Novartis Investigative Site, Heraklion Crete

75015

COMPLETED

Novartis Investigative Site, Paris

75019

RECRUITING

Novartis Investigative Site, Paris

76502

WITHDRAWN

Baylor Scott and White Research, Temple

80045

RECRUITING

Childrens Hospital Colorado, Aurora

91054

COMPLETED

Novartis Investigative Site, Erlangen

100034

RECRUITING

Novartis Investigative Site, Beijing

100730

WITHDRAWN

Novartis Investigative Site, Beijing

110029

RECRUITING

Novartis Investigative Site, New Delhi

200040

COMPLETED

Novartis Investigative Site, Shanghai

226014

RECRUITING

Novartis Investigative Site, Lucknow

248001

WITHDRAWN

Novartis Investigative Site, Dehradun

430022

WITHDRAWN

Novartis Investigative Site, Wuhan

500058

WITHDRAWN

Novartis Investigative Site, Hyderabad

510080

WITHDRAWN

Novartis Investigative Site, Guangzhou

4941492

RECRUITING

Novartis Investigative Site, Petah Tikva

02115

WITHDRAWN

Brigham and Womens Hosp Harvard Med School, Boston

C1181ACH

WITHDRAWN

Novartis Investigative Site, CABA

W3400ABH

COMPLETED

Novartis Investigative Site, Buenos Aires

X5016KET

WITHDRAWN

Novartis Investigative Site, Córdoba

30150-221

RECRUITING

Novartis Investigative Site, Belo Horizonte

50740-900

RECRUITING

Novartis Investigative Site, Pernambuco

99010-260

RECRUITING

Novartis Investigative Site, Passo Fundo

893227-680

WITHDRAWN

Novartis Investigative Site, Joinville

09090-790

RECRUITING

Novartis Investigative Site, Santo André

04038-002

RECRUITING

Novartis Investigative Site, São Paulo

05403 000

RECRUITING

Novartis Investigative Site, São Paulo

40301-155

RECRUITING

Novartis Investigative Site, Salvador

N6A 5W9

RECRUITING

Novartis Investigative Site, London

M5G 2C4

WITHDRAWN

Novartis Investigative Site, Toronto

H3T 1C5

RECRUITING

Novartis Investigative Site, Montreal

115 27

RECRUITING

Novartis Investigative Site, Athens

GR-54642

WITHDRAWN

Novartis Investigative Site, Thessaloniki

RECRUITING

Novartis Investigative Site, Thessaloniki

110 017

RECRUITING

Novartis Investigative Site, New Delhi

00165

RECRUITING

Novartis Investigative Site, Roma

466 8560

COMPLETED

Novartis Investigative Site, Nagoya

078 8510

COMPLETED

Novartis Investigative Site, Asahikawa

060-8543

COMPLETED

Novartis Investigative Site, Sapporo

569 1192

RECRUITING

Novartis Investigative Site, Takatsuki

520-2192

RECRUITING

Novartis Investigative Site, Ohtsu

951 8520

COMPLETED

Novartis Investigative Site, Niigata

2333 ZA

COMPLETED

Novartis Investigative Site, Leiden

6500HB

RECRUITING

Novartis Investigative Site, Nijmegen

08025

WITHDRAWN

Novartis Investigative Site, Barcelona

08035

WITHDRAWN

Novartis Investigative Site, Barcelona

RECRUITING

Novartis Investigative Site, Barcelona

06500

RECRUITING

Novartis Investigative Site, Ankara

G51 4TF

WITHDRAWN

Novartis Investigative Site, Glasgow

W12 0HS

RECRUITING

Novartis Investigative Site, London

NE7 7DN

RECRUITING

Novartis Investigative Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY